Arkaiya SA

Arkaiya SA detects microbiome deficiencies in toddlers.

Arkaiya SA specializes in developing advanced microbiome diagnostic tools, focusing on early detection of microbiome deficiencies in toddlers. Our flagship product is a PCR test for Methanobrevibacter smithii, a crucial gut archaea linked to mucosal integrity and reduced inflammation. By partnering with leading institutions like EPFL and Nestlé Research, Arkaiya aims to set the gold standard for microbiome diagnostics during the critical first thousand days of life. Our mission is to provide reliable, cost-effective solutions that support early childhood health and development, leveraging cutting-edge research and innovation in the field of microbiome science.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

10.03.2023

Patent human diagnostics & therapeutics

Milestone

01.01.2022

FIT Innogrant

Deal

15.05.2021

EPFL Techlaunchpad

Deal

03.03.2021

Venture Kick stage

Deal

12.07.2018

Patent granted

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Website

Arkaiya SA

Arkaiya SA detects microbiome deficiencies in toddlers.

Headquarter:
Lausanne

Foundation Date:
January 2023

Technology:

  • Biotech

Sectors:

  • Biotech
  • Food

Support received

  • Support venturekick